15234027

Source:http://linkedlifedata.com/resource/pubmed/id/15234027

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0282461, umls-concept:C0443252, umls-concept:C0684249, umls-concept:C1274040, umls-concept:C1522449
pubmed:issue	4
pubmed:dateCreated	2004-7-5
pubmed:abstractText	This Phase III study was performed to determine whether twice-daily (b.i.d.) radiotherapy (RT) resulted in better survival than once-daily (q.d.) RT for patients with limited-stage small-cell lung cancer (LD-SCLC).
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA 15083, http://linkedlifedata.com/resource/pubmed/grant/CA 25224, http://linkedlifedata.com/resource/pubmed/grant/CA 35101, http://linkedlifedata.com/resource/pubmed/grant/CA 35103, http://linkedlifedata.com/resource/pubmed/grant/CA 35113, http://linkedlifedata.com/resource/pubmed/grant/CA 35195, http://linkedlifedata.com/resource/pubmed/grant/CA 35269, http://linkedlifedata.com/resource/pubmed/grant/CA 35272, http://linkedlifedata.com/resource/pubmed/grant/CA 35415, http://linkedlifedata.com/resource/pubmed/grant/CA 35448, http://linkedlifedata.com/resource/pubmed/grant/CA 37404, http://linkedlifedata.com/resource/pubmed/grant/CA 37417, http://linkedlifedata.com/resource/pubmed/grant/CA 52352, http://linkedlifedata.com/resource/pubmed/grant/CA 60276, http://linkedlifedata.com/resource/pubmed/grant/CA 63826, http://linkedlifedata.com/resource/pubmed/grant/CA 63848, http://linkedlifedata.com/resource/pubmed/grant/CA 63849
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/15234027-15234025
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7603616
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Etoposide
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0360-3016
pubmed:author	pubmed-author:ArusellRobert MRM, pubmed-author:BonnerJames AJA, pubmed-author:BrooksBurke JBJ, pubmed-author:FarrGist HGHJr, pubmed-author:GeoffroyFrancois JFJ, pubmed-author:GeyerSusan MSM, pubmed-author:HillmanShauna LSL, pubmed-author:JettJames RJR, pubmed-author:KrookJames EJE, pubmed-author:MailliardJames AJA, pubmed-author:MarksRandolph SRS, pubmed-author:SalimMuhammadM, pubmed-author:SchaeferPaul LPL, pubmed-author:SchildSteven ESE, pubmed-author:ShanahanThomas GTG, pubmed-author:TazelaarHenry DHD
pubmed:issnType	Print
pubmed:day	15
pubmed:volume	59
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	943-51
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:15234027-Adult, pubmed-meshheading:15234027-Aged, pubmed-meshheading:15234027-Aged, 80 and over, pubmed-meshheading:15234027-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:15234027-Carcinoma, Small Cell, pubmed-meshheading:15234027-Cisplatin, pubmed-meshheading:15234027-Combined Modality Therapy, pubmed-meshheading:15234027-Cranial Irradiation, pubmed-meshheading:15234027-Dose Fractionation, pubmed-meshheading:15234027-Etoposide, pubmed-meshheading:15234027-Female, pubmed-meshheading:15234027-Humans, pubmed-meshheading:15234027-Lung Neoplasms, pubmed-meshheading:15234027-Male, pubmed-meshheading:15234027-Middle Aged, pubmed-meshheading:15234027-Radiotherapy, pubmed-meshheading:15234027-Survival Analysis
pubmed:year	2004
pubmed:articleTitle	Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer.
pubmed:affiliation	Mayo Clinic and Mayo Foundation, Rochester, MN, USA. sschild@mayo.edu
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Multicenter Study, Clinical Trial, Phase III